Why The Corbus Pharmaceuticals Holdings Inc (CRBP) Cystic Fibrosis Results Are Very Positive
Last week, Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) announced data from a Phase II study of its lead development asset Anabasum.
Author Archive - Market Exclusive
Cannabis Space Continues To Shine As Latest IPO Therapix BioSciences (TRPX) Oversubscribed
The cannabis space has been one of the most closely watched, and the most active, sectors across the last twelve months.
FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug
AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S.
Nektar Therapeutics (NKTR): Here’s What Just Happened
Nektar Therapeutics (NASDAQ:NKTR) is one of the week’s biggest winners in biotech so far, with the company soaring during the Monday session on the release of a fresh round ...
AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals
In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million in the respiratory biopharmaceutical...
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Launches Minastrin Generic In The United States
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has unveiled the authorized generic version of Minastrin, an oral contraceptive that is combined with progestin/estrogen.
Esperion Therapeutics Inc (ESPR): Get It While It’s Cheap
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha.
Positive Results Reported For Ocular Therapeutix Inc (OCUL) Dextenza Following Phase III Study
Positive results for the Phase III study meant to test the experiences of patients using the eye insert known as Dextenza to relieve pain in a post-surgical situation have been...
Seres Therapeutics Inc (MCRB) Announces New “Poop Pill” Phase 2 Study
Plans to start a new Phase II study of SER-109, branded ECOSPOR III, have been announced by Seres Therapeutics Inc (NASDAQ:MCRB).
Biotech Movers On Friday: Neurotrope Inc (NTRP) And PTC Therapeutics, Inc. (PTCT)
Here’s a look at some of the week’s biggest movers in biotech, what’s moving them, and where we expect things to go early next week and beyond.
Transcatheter Device By Medtronic PLC (MDT) Gets FDA Nod
The Melody Transcatheter Pulmonary Valve that has been developed by Medtronic PLC. Ordinary Shares (NYSE:MDT) has been approved by the U.S. Food and Drug Administration.
Merck & Co., Inc. (MRK) Sued By Numerous Plaintiffs Over Harm Caused By Its Zostavax Drug
Reports indicate that there are a number of plaintiffs filing lawsuits against Merck & Co., Inc.
Flexi-Pricing Scheme Unveiled For Novartis AG (ADR) (NVS) Kisqali In The Face Of Stiff Competition
After recently getting the approval of the U.S.
AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)
Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression.
Catalyst Pharmaceuticals Inc (CPRX): Here’s What’s Next
After struggling throughout the latter half of 2016 with various development and regulatory pressures, Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) has finally found some reprieve...
Aurinia Pharmaceuticals Inc (AUPH) In A Common Shares Public Offering To Raise Over $150 Million
In the Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) public offering, common shares totaling 22,300,000 will be offered at $6.75 a share.
Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)
It’s been a big week for PARP inhibitors.
CVS Health Corp (CVS) Pledges Funds For Youth Anti-Smoking Campaign
In its efforts to contribute to a generation that is tobacco-free, CVS Health Corp (NYSE:CVS) has devoted $50 million for a five-year program.
AstraZeneca PLC (ADR) (AZN) Rejected Drugs To Be Reconsidered
AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially meant to treat.
Two Biotech Catalysts To Watch Right Now: Bioline RX Ltd (BLRX) And AMAG Pharmaceuticals, Inc. (AMAG)
It’s been a busy quarter in the biotechnology space, but it’s not over yet.
3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)
Pershing Square Capital Management, managed by Bill Ackman, sold its entire stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Monday.
Food And Drug Administration Accepts Allergan PLC (AGN) Vraylar For Review As A Supplemental Drug
Allergan plc Ordinary Shares (NYSE:AGN) has announced that an application to have new clinical data for Vraylar evaluated has been accepted by the Food and Drug Administration...
Coverage For Medtronic PLC (MDT) Micra Approved By Centers For Medicare & Medicaid
The Centers for Medicare & Medicaid Services (CMS) has granted approval to the Micra Transcatheter pacemaker (Micra TPS) that is manufactured by Medtronic plc.
Is The Radius Health Inc (RDUS) Dip A Discount Opportunity?
Every so often, a biotech company takes a hit on some news that seems negative, and at first glance is, but is likely only temporary in terms of impact.
German Court Rules In Favor Of Boston Scientific Corporation (BSX) In Patent Case Against Edwards Lifesciences Corp (EW)
A court in Germany has ruled that patents held by Boston Scientific Corporation (NYSE:BSX) were infringed upon by Edwards Lifesciences Corp (NYSE:EW).
Here’s What’s Moving Immunomedics, Inc. (IMMU) And Ocera Therapeutics Inc (OCRX)
Yet again we’ve had a pretty busy week in the biotech space.
Access For Reversal Drug For Opioid Overdose Expanded By CVS Health Corp (CVS)
CVS Health Corp (NYSE:CVS) has announced that patients in four more states who don’t have an individual prescription will be allowed to get naloxone, a reversal drug for opioid...
Here’s Our Take On The Global Blood Therapeutics Inc (GBT) Rumors
Global Blood Therapeutics Inc (NASDAQ:GBT) is spiking towards the end of the week on the suggestion that it might be an acquisition target for a big pharma name.
Pfizer Inc. (PFE) Reportedly In Talks To Expand Plant In Lee County
Reports allege that Pfizer Inc. (NYSE:PFE) is holding talks with Lee County officials as it considers investing $100 million to expand a plant located in Sanford.
Positive Results For AbbVie Inc (ABBV) Humira Biosimilar Reported By Novartis AG (ADR) (NVS)
A Phase III study has shown that GP2017, which is manufactured by Sandoz, a unit of Novartis AG (ADR) (NYSE:NVS), has shown positive results as a Humira biosimilar.
Answering The Important Aurinia Pharmaceuticals Inc (AUPH) Questions
Last week we looked at development stage biotechnology company Aurinia Pharmaceuticals Inc (NASDAQ:AUPH).
FDA Endorses 3 New Drug Applications (NDAs) From Merck & Co., Inc. (MRK), Pfizer Inc. (PFE)
The U.S. Food and Drug Administration (FDA) has acknowledged the filing for review of three New Drug Applications (NDAs) from Merck & Co., Inc. (NYSE:MRK) and Pfizer Inc.
Eli Lilly And Co (LLY) Taltz Has A Higher Response Rate Than Stelara For Psoriasis
Detailed results from the IXORA-S study have revealed that Taltz (ixekizumab) has superior efficacy compared to Stelara (ustekinumab).
Here’s What’s Next For TG Therapeutics Inc (TGTX)
TG Therapeutics Inc (NASDAQ:TGTX) is a big runner this week, with the company up close t 90% during Monday’s session alone out of the US.
Perrigo Company PLC (PRGO) Becomes The Latest Pharma Investigated Over Price Fixing
The prices of Perrigo Company plc Ordinary Shares (NYSE:PRGO) drugs used in skin treatments is being examined by law enforcement authorities.
In A Blow To AbbVie Inc (ABBV) Humira, Market For Biosimilars Opened Wide
Two patents that AbbVie Inc (NYSE:ABBV) held on Humira, a treatment for arthritis, have been invalidated by an English court.
Two Biotechs To Watch This Week: Novan Inc (NOVN) And MannKind Corporation (MNKD)
Last week we saw plenty of volatility across the healthcare and biotechnology sectors, driven both by macro and micro factors.
Novartis AG (ADR) (NVS) Fined And Some Products To Be Temporarily Suspended In South Korea
Novartis AG (ADR) (NYSE:NVS) has been fined approximately $174,000 in South Korea after the company was found guilty of bribing physicians in order to induce them to recommend...
CVS Health Corp (CVS) Specialty Turns To New Record System For More Efficiency
Epic’s EHR systems has been selected for use by CVS Health Corp (NYSE:CVS) in its programs for care management.
Here’s What Happened To Karyopharm Therapeutics Inc (KPTI) And PTC Therapeutics, Inc. (PTCT)
The end of the week is upon us, and it’s been a bit of a wild ride in the biotech space.
Perrigo Company PLC (PRGO) Drug Gets FDA Approval
Axiron topical solution is used in the treatment of adult men who are suffering from low levels of testosterone or who lack any testosterone at all as a result of certain health...
Corbus Pharmaceuticals Holdings Inc (CRBP) Share Offering Hints At $7 Floor With Threatening Short Squeeze
In most cases, equity financings below market are bad news for shareholders. There are exceptions though.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Mylan N.V. (MYL) Accused Of Price Fixing By 20 More States
The number of states accusing Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) and Mylan N.V.
Amicus Therapeutics, Inc. (FOLD) Could Be The Force That Brings Change To The FDA
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S.
Patient Death Fears Allayed For Aurinia Pharmaceuticals Inc (AUPH), What’s Next?
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is a real winner towards the end of this week, on a fresh batch of data from its lead lupus study.
Perrigo Company PLC (PRGO) Sells Rights To Tysabri
The royalty stream that Perrigo Company plc Ordinary Shares (NYSE:PRGO) used to get from Tysabri has been sold to Royalty Pharma.
Here’s What’s Next For Lexicon Pharmaceuticals, Inc. (LXRX) And Dynavax Technologies Corporation (DVAX)
Two companies have logged strong starts to the week in the biotech space so far, and both are moving on FDA driven catalysts.
Priority Review Granted To Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Tardive Dyskinesia Drug
An application for a new drug by Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been accepted by the Food and Drug Administration.
BioCryst Pharmaceuticals, Inc. (BCRX): A Discount Entry?
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has caught our attention in the biotech space as being a company that has had a bit of a strange start to the week.
Heron Therapeutics Inc (HRTX) Sustol To Be Included In Antiemesis Guidelines By NCCN
In new guidelines, Heron Therapeutics Inc (NASDAQ:HRTX) has announced that Sustol will be included as an extended-release injection.
